Literature DB >> 34636955

Association between viral infection other than human papillomavirus and risk of esophageal carcinoma: a comprehensive meta-analysis of epidemiological studies.

Hui Geng1, Yaqi Xing2, Jingbing Zhang1, Kexin Cao1, Meijie Ye1, Geng Wang3, Caixia Liu4.   

Abstract

BACKGROUND: Infection with viruses such as human papillomavirus (HPV) is known to induce carcinomas, including esophageal carcinoma (EC). However, the possible role of viruses other than HPV in EC carcinogenesis is unclear in many studies. Here, we aimed to explore the association between infection with viruses other than HPV and EC risk by integrating existing studies of epidemiology in a meta-analysis.
METHODS: The PubMed, Web of Science, Cochrane Library and China National Knowledge Infrastructure databases were searched. The Newcastle-Ottawa scale was used to assess the quality of the included studies. Odds ratios (ORs) or relative risks (RRs) (with 95% confidence intervals [CIs]) were pooled to estimate the association between virus infection and risk of EC.
RESULTS: We included 31 eligible studies involving nine different viruses. Overall, an increased risk of EC was associated with hepatitis B virus (HBV) infection (OR = 1.19, 95%CI 1.01-1.36) and hepatitis C virus (HCV) infection (OR = 1.77, 95%CI 1.17-2.36), but not human immunodeficiency virus (HIV) infection, according to the current evidence. The evidence for an association with Epstein-Barr virus (EBV), herpes simplex virus 1 (HSV-1), JC virus (JCV), cytomegalovirus (CMV), human T-lymphotropic virus 1 (HTLV-1) or Merkel cell polyomavirus (MCPyV) infection was insufficient.
CONCLUSIONS: We confirmed the relationship between HBV and HCV infection and the risk of EC, but we found no association of EC risk with HIV and EBV infection. The roles of HSV-1, JCV, CMV, HTLV-1, and MCPyV were not clear because of the limited number of studies.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Mesh:

Year:  2021        PMID: 34636955     DOI: 10.1007/s00705-021-05268-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  69 in total

1.  Correlation of oxidative stress in patients with HBV-induced liver disease with HBV genotypes and drug resistance mutations.

Authors:  Jianbo Xianyu; Jiafu Feng; Yuwei Yang; Jie Tang; Gang Xie; Lingying Fan
Journal:  Clin Biochem       Date:  2018-03-27       Impact factor: 3.281

2.  Altered expression of TGF-beta receptors in hepatocellular carcinoma--effects of a constitutively active TGF-beta type I receptor mutant.

Authors:  Annemarie Musch; Christian Rabe; Mignon-Denise Paik; Marc Jean Berna; Volker Schmitz; Per Hoffmann; Hans Dieter Nischalke; Tilman Sauerbruch; Wolfgang H Caselmann
Journal:  Digestion       Date:  2005-03-16       Impact factor: 3.216

Review 3.  IL-18 and IL-1β Gene Polymorphisms: The Plausible Risk Factors for Chronic Hepatitis B.

Authors:  Sahar Amirpour-Rostami; Mohammad Kazemi Arababadi
Journal:  Viral Immunol       Date:  2019-05-14       Impact factor: 2.257

Review 4.  Why do viruses cause cancer? Highlights of the first century of human tumour virology.

Authors:  Patrick S Moore; Yuan Chang
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

Review 5.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

6.  Increased Oxidative Stress and RUNX3 Hypermethylation in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma (HCC) and Induction of RUNX3 Hypermethylation by Reactive Oxygen Species in HCC Cells.

Authors:  Poonsin Poungpairoj; Patcharawalai Whongsiri; Surasit Suwannasin; Apichaya Khlaiphuengsin; Pisit Tangkijvanich; Chanchai Boonla
Journal:  Asian Pac J Cancer Prev       Date:  2015

7.  High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.

Authors:  Vincent Wai-Sun Wong; Jun Yu; Alfred Sze-Lok Cheng; Grace Lai-Hung Wong; Hoi-Yun Chan; Eagle Siu-Hong Chu; Enders Kai-On Ng; Francis Ka-Leung Chan; Joseph Jao-Yao Sung; Henry Lik-Yuen Chan
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

8.  The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes.

Authors:  E Lara-Pezzi; P L Majano; M Gómez-Gonzalo; C García-Monzón; R Moreno-Otero; M Levrero; M López-Cabrera
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 10.  Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.

Authors:  Bei Zhang; Siqi Han; Bing Feng; Xiaoyuan Chu; Longbang Chen; Rui Wang
Journal:  Exp Mol Med       Date:  2017-02-10       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.